A Research Center of Excellence dedicated to the study and treatment of cognitive and behavioral disorders is located at Columbia University Medical Center. The Center, situated within the Taub Institute and Department of Neurology Division of Aging and Dementia, brings together a multidisciplinary team to address complex neurological conditions.
Comprehensive Care and Evaluation
The Center provides comprehensive diagnostic evaluations and ongoing management for individuals experiencing cognitive and behavioral changes. These evaluations utilize a range of tools, including cognitive testing, and advanced imaging techniques like magnetic resonance imaging (MRI), DaT scans, SPECT scans, and PET scans. Laboratory and biomarker studies are also employed as part of the diagnostic process.
Beyond diagnosis, the Center offers social and case assistance services. These services are supported, in part, by funding from the Fresh York State funded Columbia University Center of Excellence for Alzheimer’s Disease (CEAD).
Advancing Research Through Participation
The Center actively engages in research, offering opportunities for participation in both observational studies and clinical drug trials. This commitment to research could lead to a better understanding of cognitive disorders and the development of new treatments.
A possible next step for the Center could be expanding its research initiatives to encompass a wider range of cognitive and behavioral disorders. Further development of the Center’s capabilities may also involve incorporating new technologies and diagnostic methods.
Frequently Asked Questions
What types of professionals work at the Center?
The Center includes nine neurology specialists, four advanced nurse practitioners, two social workers, and clinical and research staff.
What kinds of evaluations are offered?
Evaluations may include cognitive testing, magnetic resonance imaging (MRI), nuclear medicine imaging (DaT, SPECT, and PET scans), and laboratory and biomarker studies.
Is financial assistance available for patients?
The Center provides social and case assistance services, supported in part by the New York State funded Columbia University Center of Excellence for Alzheimer’s Disease (CEAD).
How might increased participation in research studies impact the future of cognitive disorder treatment?
